Clinical Trial Update: Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age [NA]

View source ↗

Summary

The trial update reports on the efficacy of the PARI LC Sprint Sp Nebulizer for acute asthma attacks in hospitalized children under 36 months; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PARI LC Sprint Sp Nebulizer

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Asthma | NA | Status: COMPLETED